Fine Foods & Pharmaceuticals NTM SpA


Fine Foods & Pharmaceuticals NTM SpA

Health CarePharmaceuticals & Biotechnology
  • Price (EUR)10.60
  • Today's Change0.150 / 1.44%
  • Shares traded5.02k
  • 1 Year change3.92%
  • Beta0.1893
Data delayed at least 15 minutes, as of Sep 30 2020 16:35 BST.
More ▼

Events & Activity

  • FF:MIL trading volume exceeds daily average by +105.14%
  • FF:MIL price moved over -2.35% to 10.40
  • FF:MIL price rises above 15-day moving average to 10.80 at 10:00 BST

Key statistics

On Wednesday, Fine Foods & Pharmaceuticals NTM SpA (FF:MIL) closed at 10.60, -15.20% below its 52-week high of 12.50, set on Feb 06, 2020.
52-week range
8.70Mar 18 202012.50Feb 06 2020
Previous close10.45
Average volume3.23k
Shares outstanding18.81m
Free float1.83m
P/E (TTM)38.12
Market cap196.61m EUR
EPS (TTM)0.2742
Annual div (ADY)0.12
Annual div yield (ADY)1.15%
Div ex-dateMay 11 2020
Div pay-dateMay 13 2020
Data delayed at least 15 minutes, as of Sep 30 2020 16:35 BST.
More ▼
The Financial and Risk business of Thomson Reuters is now Refinitiv
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
Markit Short Selling Activity © Markit. All rights reserved.
Although Markit has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of Markit on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.